EFV/FTC/TDF
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EFV/FTC/TDF, covering 2017-10-19 to 2017-10-19. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate Switching From a Regimen Consisting of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate (EFV/FTC/TDF) Fixed Dose Combination (FDC) to Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) FDC in Virologically-Suppressed, HIV-1 Infected Adults [Phase 3]